Key result
CIMT-determined vascular age reclassifies cardiovascular risk in ~36% of asymptomatic T2D patients versus chronological age.
Why the study?
Cardiovascular outcomes vary widely in asymptomatic patients with T2DM, prompting investigation into the relationship between CIMT-determined vascular age, cardiovascular risk scores, and thyroid function.
Does Framingham risk score calculated using CIMT-determined vascular age improve cardiovascular risk reclassification compared to chronological age in asymptomatic patients with type 2 diabetes?
Cross-Sectional (n=154)
Does Framingham risk score calculated using CIMT-determined vascular age improve cardiovascular risk reclassification compared to chronological age in asymptomatic patients with type 2 diabetes?
Using CIMT-determined vascular age instead of chronological age in the Framingham risk score reclassifies cardiovascular risk in over a third of asymptomatic patients with type 2 diabetes.
May refine FRS-based risk assessment in asymptomatic T2DM; leaves open whether reclassification improves outcomes or warrants prospective validation.
AIM: There is a wide variety of cardiovascular outcomes in patients with type 2 diabetes (T2DM), even in asymptomatic individuals. Carotid intima-media thickness (CIMT) is a marker of subclinical atherosclerosis and can be considered as a predictor of cardiovascular risk (CVR). The aim of this study was to evaluate the relationship between CIMT-determined vascular age (VA), CVR scores, and thyroid function in asymptomatic patients with T2DM. PATIENTS AND METHODS: Clinical laboratory and CIMT parameters were measured in 154 asymptomatic patients with T2DM. The Framingham risk score (FRS) was performed with chronological age (CA) and with VA. A multinomial logistic regression model was used to analyze variables related to CVR reclassification. RESULTS: The use of CIMT-determined VA led to the reclassification of 54 (35.52%) out of 152 asymptomatic T2DM patients, being 20 (37.03%) to a lower categorical risk and 34 (62.96%) to a higher categorical risk according to FRS. The variables that were associated to reclassification to a higher categorical risk were positive family history (FH) of premature coronary artery disease (p=0.046), FH of thyroid disease (p=0.010), use of statins (p=0.027), and free T4 levels (p=0.009). CONCLUSION: VA determined from CIMT allowed the reclassification of the CVR in asymptomatic T2DM patients. FH of premature CAD, FH of known thyroid disease, use of statins, and free T4 levels were associated to a reclassification into a higher risk category. The use of doppler to perform CIMT measure is currently more accessible, especially in a low-middle income country like Brazil. However, further prospective studies must be performed to establish the predictive values of CIMT on atherosclerosis and how thyroid function acts like cardiovascular risk marker on CVR scores.
No takes yet. Share an insight, caveat, or question.
Palma et al. (2020) conducted a cross-sectional in Type 2 Diabetes (n=154). CIMT-determined vascular age vs. Chronological age was evaluated on Cardiovascular risk reclassification according to Framingham risk score. CIMT-determined vascular age led to cardiovascular risk reclassification in 35.52% of asymptomatic patients with type 2 diabetes compared to chronological age.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: